| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vesicular stomatitis Indiana virus | 31 | 2016 | 42 | 7.560 |
Why?
|
| Viral Matrix Proteins | 27 | 2013 | 34 | 5.870 |
Why?
|
| Vesiculovirus | 11 | 2015 | 14 | 3.110 |
Why?
|
| Oncolytic Virotherapy | 7 | 2015 | 19 | 1.800 |
Why?
|
| Virus Assembly | 7 | 2016 | 12 | 1.780 |
Why?
|
| Apoptosis | 9 | 2011 | 337 | 1.690 |
Why?
|
| Virus Replication | 10 | 2019 | 47 | 1.550 |
Why?
|
| Cytoplasm | 4 | 2016 | 30 | 1.520 |
Why?
|
| Viral Envelope Proteins | 7 | 2015 | 15 | 1.370 |
Why?
|
| Dendritic Cells | 4 | 2013 | 61 | 1.360 |
Why?
|
| Nucleocapsid | 4 | 2016 | 6 | 1.350 |
Why?
|
| Membrane Glycoproteins | 6 | 2015 | 97 | 1.300 |
Why?
|
| Vesicular Stomatitis | 4 | 2013 | 5 | 1.260 |
Why?
|
| Oncolytic Viruses | 4 | 2015 | 10 | 1.090 |
Why?
|
| Cell Line | 19 | 2012 | 450 | 1.040 |
Why?
|
| Transcription, Genetic | 6 | 2012 | 136 | 1.040 |
Why?
|
| Animals | 38 | 2015 | 7299 | 1.020 |
Why?
|
| Protein Biosynthesis | 5 | 2007 | 46 | 0.980 |
Why?
|
| Mutation | 14 | 2013 | 466 | 0.970 |
Why?
|
| Hela Cells | 12 | 2016 | 78 | 0.960 |
Why?
|
| Cricetinae | 16 | 2012 | 58 | 0.910 |
Why?
|
| Host-Pathogen Interactions | 3 | 2013 | 30 | 0.890 |
Why?
|
| RNA Viruses | 3 | 2013 | 3 | 0.870 |
Why?
|
| Mice | 19 | 2015 | 2370 | 0.860 |
Why?
|
| Flagellin | 2 | 2013 | 19 | 0.860 |
Why?
|
| RNA, Messenger | 11 | 2012 | 514 | 0.800 |
Why?
|
| Prostatic Neoplasms | 3 | 2015 | 441 | 0.790 |
Why?
|
| Rhabdoviridae Infections | 3 | 2008 | 4 | 0.750 |
Why?
|
| Viral Proteins | 7 | 2016 | 42 | 0.730 |
Why?
|
| Signal Transduction | 5 | 2015 | 666 | 0.680 |
Why?
|
| Genetic Vectors | 4 | 2013 | 118 | 0.650 |
Why?
|
| Membrane Microdomains | 3 | 2009 | 24 | 0.610 |
Why?
|
| Microtubules | 1 | 2016 | 17 | 0.570 |
Why?
|
| Organelles | 1 | 2015 | 3 | 0.550 |
Why?
|
| Cell Membrane | 5 | 2009 | 98 | 0.540 |
Why?
|
| Cytological Techniques | 1 | 2015 | 19 | 0.540 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 4 | 2009 | 31 | 0.530 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 2 | 2012 | 2 | 0.530 |
Why?
|
| Nuclear Matrix-Associated Proteins | 2 | 2012 | 7 | 0.530 |
Why?
|
| Immunity, Innate | 2 | 2013 | 64 | 0.510 |
Why?
|
| Receptors, Death Domain | 2 | 2011 | 2 | 0.490 |
Why?
|
| Humans | 33 | 2019 | 29123 | 0.480 |
Why?
|
| Carrier Proteins | 2 | 2006 | 131 | 0.480 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 2007 | 4 | 0.470 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 1997 | 13 | 0.460 |
Why?
|
| Mutant Proteins | 2 | 2010 | 13 | 0.460 |
Why?
|
| Virus Release | 1 | 2013 | 1 | 0.450 |
Why?
|
| Interferon-beta | 5 | 2015 | 23 | 0.450 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2012 | 6 | 0.440 |
Why?
|
| Mononegavirales | 1 | 2011 | 1 | 0.410 |
Why?
|
| Mononegavirales Infections | 1 | 2011 | 1 | 0.410 |
Why?
|
| Antibodies, Viral | 2 | 2010 | 55 | 0.410 |
Why?
|
| Models, Biological | 2 | 2011 | 373 | 0.400 |
Why?
|
| JC Virus | 3 | 2019 | 23 | 0.380 |
Why?
|
| Genetic Engineering | 1 | 2010 | 19 | 0.380 |
Why?
|
| Gene Expression | 4 | 2015 | 332 | 0.370 |
Why?
|
| Vaccinia virus | 1 | 2010 | 15 | 0.370 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2009 | 4 | 0.360 |
Why?
|
| bcl-X Protein | 1 | 2009 | 6 | 0.360 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2009 | 14 | 0.360 |
Why?
|
| Phosphoproteins | 2 | 2016 | 54 | 0.350 |
Why?
|
| Glioblastoma | 1 | 2011 | 143 | 0.350 |
Why?
|
| Cell Line, Tumor | 8 | 2015 | 681 | 0.340 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 208 | 0.340 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2008 | 4 | 0.340 |
Why?
|
| Mice, Nude | 6 | 2013 | 276 | 0.330 |
Why?
|
| Cytopathogenic Effect, Viral | 2 | 2006 | 5 | 0.330 |
Why?
|
| RNA, Viral | 5 | 2011 | 49 | 0.320 |
Why?
|
| Gene Expression Regulation | 4 | 2005 | 481 | 0.310 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2007 | 8 | 0.300 |
Why?
|
| Cells, Cultured | 4 | 2013 | 799 | 0.300 |
Why?
|
| Fas Ligand Protein | 1 | 2006 | 7 | 0.300 |
Why?
|
| eIF-2 Kinase | 1 | 2006 | 8 | 0.300 |
Why?
|
| Genome, Viral | 1 | 2006 | 12 | 0.290 |
Why?
|
| Microscopy, Immunoelectron | 5 | 2012 | 8 | 0.290 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 72 | 0.290 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 71 | 0.290 |
Why?
|
| Mice, Inbred C57BL | 4 | 2013 | 711 | 0.280 |
Why?
|
| Antiviral Agents | 1 | 2007 | 100 | 0.280 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2013 | 113 | 0.280 |
Why?
|
| Green Fluorescent Proteins | 2 | 2016 | 71 | 0.270 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2005 | 4 | 0.260 |
Why?
|
| RNA, Small Interfering | 3 | 2012 | 109 | 0.260 |
Why?
|
| Proteins | 2 | 2003 | 140 | 0.260 |
Why?
|
| Cell Nucleus | 2 | 2016 | 105 | 0.260 |
Why?
|
| Cell Hypoxia | 1 | 2004 | 39 | 0.250 |
Why?
|
| Mice, Knockout | 3 | 2015 | 425 | 0.250 |
Why?
|
| Peptide Initiation Factors | 1 | 2002 | 2 | 0.220 |
Why?
|
| Repressor Proteins | 1 | 2002 | 53 | 0.220 |
Why?
|
| RNA | 1 | 2003 | 88 | 0.220 |
Why?
|
| Recombinant Proteins | 3 | 2015 | 248 | 0.220 |
Why?
|
| Urinary Tract Infections | 2 | 2019 | 36 | 0.210 |
Why?
|
| Urine | 2 | 2019 | 59 | 0.200 |
Why?
|
| Transfection | 5 | 2003 | 192 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 2 | 2015 | 158 | 0.180 |
Why?
|
| RNA Interference | 2 | 2012 | 76 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 3 | 2013 | 160 | 0.180 |
Why?
|
| Virion | 2 | 2016 | 7 | 0.180 |
Why?
|
| Capsid | 2 | 1996 | 9 | 0.180 |
Why?
|
| Viral Vaccines | 2 | 2010 | 13 | 0.170 |
Why?
|
| Tumor Virus Infections | 1 | 2018 | 20 | 0.170 |
Why?
|
| Polyomavirus Infections | 1 | 2018 | 21 | 0.170 |
Why?
|
| Protein Structure, Tertiary | 3 | 2009 | 95 | 0.160 |
Why?
|
| Neoplasms | 1 | 2004 | 611 | 0.160 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 195 | 0.150 |
Why?
|
| Female | 8 | 2019 | 18173 | 0.150 |
Why?
|
| Cell Survival | 3 | 2013 | 272 | 0.150 |
Why?
|
| Demecolcine | 1 | 2016 | 2 | 0.140 |
Why?
|
| Cytochalasin D | 1 | 2016 | 3 | 0.140 |
Why?
|
| Nocodazole | 1 | 2016 | 3 | 0.140 |
Why?
|
| Viral Structural Proteins | 1 | 2016 | 7 | 0.140 |
Why?
|
| Plasmids | 4 | 2003 | 48 | 0.140 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2016 | 92 | 0.140 |
Why?
|
| Kidney Diseases | 1 | 2019 | 239 | 0.140 |
Why?
|
| Brefeldin A | 1 | 2015 | 4 | 0.140 |
Why?
|
| Fluorescence | 1 | 2015 | 21 | 0.140 |
Why?
|
| Male | 6 | 2019 | 17815 | 0.140 |
Why?
|
| Autoantigens | 1 | 2015 | 16 | 0.140 |
Why?
|
| Genes, Viral | 1 | 2015 | 3 | 0.130 |
Why?
|
| STAT1 Transcription Factor | 1 | 2015 | 12 | 0.130 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 20 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 271 | 0.130 |
Why?
|
| Cell Death | 1 | 2015 | 71 | 0.130 |
Why?
|
| Interferon-alpha | 1 | 2015 | 69 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2013 | 436 | 0.130 |
Why?
|
| Protein Conformation | 4 | 2004 | 85 | 0.130 |
Why?
|
| African Americans | 2 | 2019 | 1373 | 0.130 |
Why?
|
| Caspase 9 | 2 | 2005 | 7 | 0.120 |
Why?
|
| Caspase 8 | 2 | 2005 | 9 | 0.120 |
Why?
|
| Caspases | 2 | 2005 | 31 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2015 | 256 | 0.120 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2004 | 32 | 0.120 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 1 | 0.120 |
Why?
|
| Head and Neck Neoplasms | 1 | 2015 | 117 | 0.120 |
Why?
|
| Immunization, Secondary | 1 | 2013 | 9 | 0.120 |
Why?
|
| Neuroendocrine Tumors | 1 | 2013 | 20 | 0.120 |
Why?
|
| Phosphorylation | 2 | 2005 | 225 | 0.110 |
Why?
|
| HIV-1 | 1 | 2013 | 42 | 0.110 |
Why?
|
| Intracellular Membranes | 1 | 2013 | 10 | 0.110 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 114 | 0.110 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2013 | 91 | 0.110 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 9 | 0.110 |
Why?
|
| Disease Progression | 1 | 2015 | 572 | 0.110 |
Why?
|
| Mumps virus | 1 | 2012 | 3 | 0.110 |
Why?
|
| Complement Activation | 1 | 2012 | 10 | 0.110 |
Why?
|
| Time Factors | 3 | 2008 | 2001 | 0.110 |
Why?
|
| Microscopy, Confocal | 2 | 2009 | 62 | 0.110 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 131 | 0.110 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2011 | 1 | 0.100 |
Why?
|
| HCT116 Cells | 1 | 2011 | 11 | 0.100 |
Why?
|
| Cytosol | 1 | 2011 | 25 | 0.100 |
Why?
|
| Interferons | 1 | 2011 | 17 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2011 | 14 | 0.100 |
Why?
|
| Central Nervous System | 2 | 2008 | 29 | 0.100 |
Why?
|
| Interferon Type I | 2 | 2009 | 14 | 0.100 |
Why?
|
| Immune Tolerance | 1 | 2011 | 67 | 0.100 |
Why?
|
| Melanoma | 1 | 2012 | 148 | 0.100 |
Why?
|
| Salmonella enterica | 1 | 2010 | 5 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 301 | 0.100 |
Why?
|
| Vaccines, Attenuated | 1 | 2010 | 11 | 0.090 |
Why?
|
| Vaccines, Synthetic | 1 | 2010 | 11 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 519 | 0.090 |
Why?
|
| Immunization | 1 | 2010 | 28 | 0.090 |
Why?
|
| Arenavirus | 1 | 2009 | 1 | 0.090 |
Why?
|
| Receptor Cross-Talk | 1 | 2009 | 4 | 0.090 |
Why?
|
| Detergents | 1 | 2009 | 17 | 0.090 |
Why?
|
| B-Lymphocytes | 1 | 2010 | 69 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2003 | 212 | 0.090 |
Why?
|
| Mitochondria | 1 | 2011 | 174 | 0.090 |
Why?
|
| Brain | 2 | 2008 | 930 | 0.090 |
Why?
|
| Glycoproteins | 1 | 2009 | 34 | 0.090 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2009 | 11 | 0.090 |
Why?
|
| Temperature | 3 | 2002 | 55 | 0.080 |
Why?
|
| Virus Internalization | 1 | 2008 | 6 | 0.080 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 67 | 0.080 |
Why?
|
| Gene Silencing | 1 | 2008 | 49 | 0.080 |
Why?
|
| Nasal Mucosa | 1 | 2008 | 19 | 0.080 |
Why?
|
| Virulence | 1 | 2008 | 19 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 155 | 0.080 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 32 | 0.080 |
Why?
|
| Oligopeptides | 2 | 2004 | 51 | 0.080 |
Why?
|
| La Crosse virus | 1 | 2007 | 1 | 0.080 |
Why?
|
| Avulavirus | 1 | 2007 | 1 | 0.080 |
Why?
|
| Lactams, Macrocyclic | 1 | 2007 | 2 | 0.080 |
Why?
|
| RNA Replicase | 1 | 2007 | 2 | 0.080 |
Why?
|
| Benzoquinones | 1 | 2007 | 5 | 0.080 |
Why?
|
| Macrolides | 1 | 2007 | 8 | 0.080 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2006 | 12 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 18 | 0.070 |
Why?
|
| Protein Array Analysis | 1 | 2006 | 16 | 0.070 |
Why?
|
| Molecular Chaperones | 1 | 2006 | 12 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 35 | 0.070 |
Why?
|
| Blood Platelets | 2 | 2004 | 37 | 0.070 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 82 | 0.070 |
Why?
|
| Recombination, Genetic | 1 | 2005 | 20 | 0.070 |
Why?
|
| Caspase 12 | 1 | 2005 | 1 | 0.070 |
Why?
|
| Fluorometry | 1 | 2005 | 2 | 0.070 |
Why?
|
| Thapsigargin | 1 | 2005 | 7 | 0.070 |
Why?
|
| Amino Acid Substitution | 1 | 2005 | 40 | 0.070 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 7 | 0.070 |
Why?
|
| Protein Subunits | 1 | 2005 | 34 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2005 | 126 | 0.060 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2004 | 3 | 0.060 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 76 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2005 | 103 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2004 | 121 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2005 | 281 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 162 | 0.060 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2004 | 82 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 141 | 0.060 |
Why?
|
| Peptides | 1 | 2004 | 118 | 0.060 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 2003 | 1 | 0.060 |
Why?
|
| Dactinomycin | 1 | 2003 | 10 | 0.060 |
Why?
|
| Treatment Outcome | 1 | 2011 | 3101 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-4G | 1 | 2002 | 1 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-4F | 1 | 2002 | 2 | 0.060 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2002 | 3 | 0.060 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 2002 | 2 | 0.060 |
Why?
|
| Lung | 1 | 2004 | 233 | 0.060 |
Why?
|
| Base Sequence | 1 | 2003 | 240 | 0.060 |
Why?
|
| Sirolimus | 1 | 2002 | 35 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 65 | 0.050 |
Why?
|
| Apolipoprotein A-I | 1 | 2002 | 68 | 0.050 |
Why?
|
| Scattering, Radiation | 2 | 2002 | 7 | 0.050 |
Why?
|
| Light | 2 | 2002 | 25 | 0.050 |
Why?
|
| Protein Binding | 2 | 2002 | 199 | 0.050 |
Why?
|
| BK Virus | 1 | 2019 | 7 | 0.040 |
Why?
|
| Microscopy, Electron | 2 | 2009 | 25 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 1997 | 16 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1996 | 4 | 0.040 |
Why?
|
| PC12 Cells | 1 | 1996 | 7 | 0.040 |
Why?
|
| RNA Polymerase II | 1 | 1996 | 2 | 0.040 |
Why?
|
| Nerve Growth Factors | 1 | 1996 | 18 | 0.040 |
Why?
|
| Genotype | 1 | 2018 | 735 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 1996 | 42 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 1996 | 15 | 0.040 |
Why?
|
| Molecular Weight | 1 | 1996 | 40 | 0.040 |
Why?
|
| Sodium Chloride | 1 | 1996 | 24 | 0.040 |
Why?
|
| Genetic Complementation Test | 1 | 1996 | 5 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1996 | 11 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2018 | 859 | 0.040 |
Why?
|
| Kinetics | 1 | 1996 | 205 | 0.030 |
Why?
|
| Middle Aged | 2 | 2019 | 10834 | 0.030 |
Why?
|
| Endocytosis | 1 | 2013 | 11 | 0.030 |
Why?
|
| Immunity, Cellular | 1 | 2013 | 20 | 0.030 |
Why?
|
| Ligands | 2 | 2004 | 81 | 0.030 |
Why?
|
| DNA, Recombinant | 1 | 2013 | 9 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2013 | 53 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2004 | 178 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2013 | 90 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 2012 | 12 | 0.030 |
Why?
|
| Cricetulus | 1 | 2012 | 17 | 0.030 |
Why?
|
| CHO Cells | 1 | 2012 | 25 | 0.030 |
Why?
|
| Rats | 1 | 1996 | 1604 | 0.030 |
Why?
|
| Myristic Acid | 1 | 2009 | 1 | 0.020 |
Why?
|
| Vero Cells | 1 | 2009 | 3 | 0.020 |
Why?
|
| Octoxynol | 1 | 2009 | 7 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2009 | 11 | 0.020 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2009 | 16 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2009 | 48 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 546 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2007 | 32 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 9492 | 0.020 |
Why?
|
| Viper Venoms | 1 | 2004 | 1 | 0.020 |
Why?
|
| Dimerization | 1 | 2004 | 24 | 0.020 |
Why?
|
| Platelet Aggregation | 1 | 2004 | 21 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 100 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 980 | 0.010 |
Why?
|
| Entropy | 1 | 2002 | 8 | 0.010 |
Why?
|
| Thermodynamics | 1 | 2002 | 45 | 0.010 |
Why?
|
| Lipid Bilayers | 1 | 2002 | 6 | 0.010 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2002 | 8 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2002 | 24 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2002 | 16 | 0.010 |
Why?
|
| Binding Sites | 1 | 2002 | 125 | 0.010 |
Why?
|
| Cholesterol Esters | 1 | 2002 | 37 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2002 | 71 | 0.010 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2002 | 7 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 280 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 2002 | 77 | 0.010 |
Why?
|
| Neuroprotective Agents | 1 | 2002 | 20 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2002 | 100 | 0.010 |
Why?
|
| Cysteine | 1 | 2002 | 131 | 0.010 |
Why?
|
| Cholesterol | 1 | 2002 | 229 | 0.010 |
Why?
|
| Lipoproteins, HDL | 1 | 2002 | 247 | 0.010 |
Why?
|
| Adult | 1 | 2002 | 8426 | 0.010 |
Why?
|